OneMedNet expands its Real-World Data network, adding over 380 provider sites and millions of patient records, enhancing subscription services.
Quiver AI Summary
OneMedNet Corporation has announced a significant expansion of its iRWD™ network, positioning it as one of the largest live Real-World Data networks globally. In just three months, the company increased the number of provider sites by 22% to over 2,130, added 13 million unique de-identified patient records for a total exceeding 47 million, and expanded clinical exams and images by 50 million, bringing the total to over 186 million. This growth supports OneMedNet's subscription model, which caters to pharmaceutical, life-science, and AI customers seeking diverse data for real-world evidence. CEO Aaron Green emphasized that the incremental growth fosters deeper commitments from existing subscribers and attracts new customers, thereby accelerating annual recurring revenue. The company's platform is poised to capitalize on the expanding Real-World Evidence market, valued at $60 billion.
Potential Positives
- Significant expansion of the iRWD™ network with over 2,130 provider sites, marking a 22% increase, strengthening OneMedNet's market position.
- Increase of unique de-identified patient records by 13 million, now exceeding 47 million, enhancing the depth and diversity of data available for subscribers.
- Substantial growth in clinical exams and images by 50 million, totaling over 186 million, which adds value to the services offered to customers in the pharmaceutical and life-sciences sectors.
- The momentum of the subscription model is highlighted, indicating a positive trend for long-term partnerships and recurring revenue growth in the Real-World Evidence market.
Potential Negatives
- The press release includes numerous forward-looking statements, which carry inherent risks and uncertainties that could lead to actual results differing materially from expectations.
- The reliance on the subscription model and the emphasis on ongoing commitments from existing customers raises questions about the sustainability of revenue growth.
- While the expansion of the network is positioned positively, it implies potential operational challenges in managing the increased scale and maintaining quality control across a larger dataset.
FAQ
What is OneMedNet Corporation's recent network expansion?
OneMedNet has expanded its iRWD™ network by adding 380 provider sites, totaling over 2,130 sites.
How many unique patient records does OneMedNet now hold?
OneMedNet has increased its unique de-identified patient records by 13 million, now exceeding 47 million.
What types of data does OneMedNet's network provide?
The network provides clinical exams and images, totaling over 186 million records, in addition to patient data.
How does OneMedNet support its subscription model?
The company’s subscription model offers access to diverse, precise, and longitudinal data essential for healthcare innovation.
What industries can benefit from OneMedNet's data?
Beyond healthcare, OneMedNet's data supports sectors like finance, retail, and telecom through AI-anonymized data solutions.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$ONMD Hedge Fund Activity
We have seen 11 institutional investors add shares of $ONMD stock to their portfolio, and 10 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CORRECT CAPITAL WEALTH MANAGEMENT added 4,504,955 shares (+inf%) to their portfolio in Q3 2025, for an estimated $4,910,400
- EXENCIAL WEALTH ADVISORS, LLC added 2,107,598 shares (+141.3%) to their portfolio in Q3 2025, for an estimated $2,297,281
- VANGUARD GROUP INC added 234,739 shares (+31.4%) to their portfolio in Q3 2025, for an estimated $255,865
- HRT FINANCIAL LP removed 182,638 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $199,075
- GEODE CAPITAL MANAGEMENT, LLC added 174,885 shares (+128.0%) to their portfolio in Q3 2025, for an estimated $190,624
- CKW FINANCIAL GROUP removed 100,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $57,010
- GOLDMAN SACHS GROUP INC added 56,584 shares (+inf%) to their portfolio in Q3 2025, for an estimated $61,676
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
MINNEAPOLIS, Nov. 20, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), the curator and provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced a significant network expansion that materially strengthens its position as one of the largest live Real-World Data networks in the world and supports the company’s subscription offerings.
In the three months since August 2025, OneMedNet has expanded its iRWD™ network as follows:
- Added approximately 380 provider sites → total now exceeding 2,130 (+22% network scale)
- Increased unique de-identified patient records by 13 million → total now exceeding 47 million (+38%)
-
Expanded clinical exams and images by 50 million → total now exceeding
186 million
(+37%)
This rapid, multi-dimensional growth cements OneMedNet’s leadership as the largest continuously refreshed, regulatory-grade Real-World Data network globally.
“Our subscription model is now gaining significant momentum,” said Aaron Green, President & CEO of OneMedNet. “In the $60 billion Real-World Evidence market 1 , pharmaceutical, life-science, and AI customers subscribe to our platform for ongoing access to the precise, diverse, and longitudinal cohorts they require. Each incremental expansion of sites, encounters, and clinical exams materially enhances the depth, specificity, and value of those data feeds. The result is a powerful virtuous cycle: existing subscribers expand their commitments; new customers commit to long term partnerships and annual recurring revenue accelerates. Today’s milestone unequivocally positions OneMedNet to capture a growing share of this market opportunity.”
1 Real World Evidence Solutions Market – https://www.grandviewresearch.com/industry-analysis/real-world-evidence-solutions-market-report
About OneMedNet Corporation
OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the untapped potential of over 2,130 healthcare sites through its iRWD™ platform. This isn’t just data—it’s the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption.
Beyond healthcare OneMedNet’s proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities—rigorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information. Learn more at www.onemednet.com.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements. All statements other than statements of historical facts contained in this press release are forward-looking statements. We base these forward-looking statements on our current expectations and projections about future events, which we derive from the information presently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial and operational performance , debt reductions, and their effect on achieving operational strategies of the company. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; risks inherent with investing in Digital Assets, including Digital Asset’s volatility; and our ability to implement our Digital Asset treasury strategy and its effects on our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this press release to conform these statements to actual results or to changes in our expectations.
OneMedNet Contacts:
Michael Wong, VP Marketing
Email: [email protected]
SOURCE: ONEMEDNET CORPORATION